Association between the Interleukin-6 Promoter Polymorphism −174G/C and Serum Lipoprotein(a) Concentrations in Humans

BACKGROUND: Lipoprotein(a) [Lp(a)] is an independent risk factor for cardiovascular disease. The interleukin-6 (IL-6) receptor antagonist tocilizumab has been shown to lower serum Lp(a) concentrations. We investigated whether the IL-6 single nucleotide polymorphism −174G/C is associated with baselin...

Full description

Saved in:
Bibliographic Details
Main Authors: Berthold, Heiner K., Laudes, Matthias, Krone, Wilhelm, Gouni-Berthold, Ioanna
Format: Artigo
Language:Inglês
Published: Public Library of Science 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3173458/
https://ncbi.nlm.nih.gov/pubmed/21935443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0024719
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items